These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 13907260)

  • 1. Neuropathologic lesions in dogs after prolonged administration of phenylisopropylhydrazine (JB 516) and phenylisobutylhydrazine (JB 835).
    HIGHMAN B; MALING HM
    J Pharmacol Exp Ther; 1962 Sep; 137():344-55. PubMed ID: 13907260
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurologic, neuropathologic, and neurochemical effects of prolonged administration of phenylisopropylhydrazine (JB 516), phenylisobutylhydrazine (JB 835), and other monoamine oxidase inhibitors.
    MALING HM; HIGHMAN B; SPECTOR S
    J Pharmacol Exp Ther; 1962 Sep; 137():334-43. PubMed ID: 14468916
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical and pharmacological effects of the monoamine oxidase inhibitors, iproniazid, 1-phenyl-2-hydrazinopropane (JB 516) and 1-phenyl-3-hydrazinobutane (JB 835).
    SPECTOR S; SHORE PA; BRODIE BB
    J Pharmacol Exp Ther; 1960 Jan; 128():15-21. PubMed ID: 13833205
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of beta-phenylisopropylhydrazine (JB 516) on the isolated cerebral cortex.
    Sinha JN; Tangri KK; Bhargava KP
    Electroencephalogr Clin Neurophysiol; 1966 Sep; 21(3):301-3. PubMed ID: 4162480
    [No Abstract]   [Full Text] [Related]  

  • 5. [Derivatives of hydrazides and hydrazines inhibiting monoamine oxidase. Mechanisms cited to account for their pharmacological effects].
    LEVY J
    Actual Pharmacol (Paris); 1961; 14():125-73. PubMed ID: 14464772
    [No Abstract]   [Full Text] [Related]  

  • 6. NEUROPATHOLOGICAL EFFECTS OF PROLONGED ADMINISTRATION OF SOME HYDRAZINE MONOAMINE OXIDASE INHIBITORS IN DOGS.
    PALMER AC; NOEL PR
    J Pathol Bacteriol; 1963 Oct; 86():463-76. PubMed ID: 14068955
    [No Abstract]   [Full Text] [Related]  

  • 7. Methanesulphonic acid derivatives of central stimulant drugs.
    LOGEMANN W; LAURIA F; ARTINI D
    Nature; 1960 Feb; 185(4712):532-3. PubMed ID: 18985987
    [No Abstract]   [Full Text] [Related]  

  • 8. Some effects of a monoamine oxidase inhibitor upon changes produced by centrally administered amines.
    SCHAIN RJ
    Br J Pharmacol Chemother; 1961 Oct; 17(2):261-6. PubMed ID: 14497993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial monoamine oxidase. Mechanism of inhibition by phenylhydrazine and by aralkylhydrazines. Role of enzymatic oxidation.
    Patek DR; Hellerman L
    J Biol Chem; 1974 Apr; 249(8):2373-80. PubMed ID: 4822496
    [No Abstract]   [Full Text] [Related]  

  • 10. [New hydrazine derivatives with MAO-inhibiting action].
    DELL'OMODARME G; SANSONE M
    Arch Ital Sci Farmacol; 1961 Oct; 11():334-6. PubMed ID: 13885166
    [No Abstract]   [Full Text] [Related]  

  • 11. Facilitation of metrazol-in-duced seizures by iproniazid and betaphenylisopropylhy-drazine in mice.
    SPOERLEIN MT; ELLMAN AM
    Arch Int Pharmacodyn Ther; 1961; 133():193-9. PubMed ID: 13915887
    [No Abstract]   [Full Text] [Related]  

  • 12. [INHIBITION OF RAT BRAIN MONOAMINE OXIDASES BY BETA-PHENYLISOPROPYLHYDRAZINE AND HARMALINE: HISTOCHEMICAL STUDY OF THE ACTION OF THESE INHIBITORS AND THEIR ANTAGONISM].
    BOUCHAUD C; COUTEAUX R; GAUTRON J
    C R Hebd Seances Acad Sci; 1965 Jan; 260():348-51. PubMed ID: 14305447
    [No Abstract]   [Full Text] [Related]  

  • 13. The analgesic activity of phenelzine and other compounds.
    EMELE JF; SHANAMAN J; WARREN MR
    J Pharmacol Exp Ther; 1961 Nov; 134():206-9. PubMed ID: 13890095
    [No Abstract]   [Full Text] [Related]  

  • 14. REDUCTION OF THE CENTRAL EFFECTS OF TRYPTOPHAN BY A DECARBOXYLASE INHIBITOR.
    HODGE JV; OATES JA; SJOERDSMA A
    Clin Pharmacol Ther; 1964; 5():149-55. PubMed ID: 14155155
    [No Abstract]   [Full Text] [Related]  

  • 15. Central effects of beta-phenylisopropylhydrazine and iproniazid.
    FURGIUELE AR; KINNARD WJ; BUCKLEY JP
    J Pharmacol Exp Ther; 1962 Sep; 137():356-60. PubMed ID: 13895937
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of vetrazine in experimental exclusion of the heart from blood circulation].
    Bukov VA; Kudrin AN; Bobkov IG; Levitskaia II; Akimov PP
    Kardiologiia; 1969 Dec; 9(12):89-91. PubMed ID: 5383794
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on monoamine oxidase inhibitory action of hydrazines and other compounds].
    Xu FB; Kin KC; Chen YL; Zhang ZD
    Yao Xue Xue Bao; 1965 Oct; 12(10):650-6. PubMed ID: 5899051
    [No Abstract]   [Full Text] [Related]  

  • 18. [Central effects of betamezide].
    Mikhaĭlova TV; Gilev AP; Khavronina-Gureeva ZP
    Farmakol Toksikol; 1969; 32(6):652-6. PubMed ID: 5381593
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of p-chloramphetamine on the inactivation of monoamine oxidase in rat brain by 3-amino-2-oxazolidinone, 2-hydroxyethylhydrazine and pheylisopropylhydrazine.
    Fuller RW; Roush BW
    Arch Int Pharmacodyn Ther; 1978 Mar; 232(1):134-40. PubMed ID: 666453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of tyramine and cheese on the blood pressure and their modification by DL-serine-N2-isopropylhydrazide (Ro 4-1038) on awake intact dogs].
    Gerold M
    Arzneimittelforschung; 1968 Sep; 18(9):1198-200. PubMed ID: 5755936
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.